Heritas Capital continues backing Tessa Therapeutics in its US$126 million Series A round led by Polaris Partners
Heritas-backed Tessa Therapeutics has raised US$126 million in a Series A funding round led by US healthcare investor Polaris Partners, alongside existing investors Temasek, EDBI, Heliconia Capital and Heritas Capital. “Heritas Capital is pleased to join Polaris Partners, Temasek, EDBI and Heliconia Capital in backing Tessa Therapeutics to advance its...